B cell-targeted immunotherapy for type 1 diabetes: What can make it work? [electronic resource]
Producer: 20171102Description: 213-9 p. digitalISSN:- 1944-7930
- Animals
- Antigens, CD20 -- immunology
- Autoimmunity -- drug effects
- B-Lymphocytes -- drug effects
- Clinical Trials as Topic
- Diabetes Mellitus, Type 1 -- therapy
- Drug Therapy, Combination
- Fas Ligand Protein -- antagonists & inhibitors
- Humans
- Immunologic Factors -- adverse effects
- Immunotherapy -- adverse effects
- Interleukin-10 -- metabolism
- Islets of Langerhans -- immunology
- Islets of Langerhans Transplantation -- immunology
- Mice
- Rituximab -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.